Deutsch English Français

Contact

EP2629775

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2629775

EP2629775 - SUSTAINED-RELEASE FORMULATION FOR INJECTION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.10.2020 Database last updated on 30.10.2024
Former	Grant of patent is intended Status updated on 29.01.2020
Former	Examination is in progress Status updated on 15.10.2019
Former	Grant of patent is intended Status updated on 28.05.2019
Former	Examination is in progress Status updated on 26.04.2019
Former	Grant of patent is intended Status updated on 13.12.2018
Former	Examination is in progress Status updated on 22.03.2018
Most recent event Tooltip	16.10.2020	Application deemed to be withdrawn	published on 18.11.2020 [2020/47]
Applicant(s)	For all designated states Sumitomo Dainippon Pharma Co., Ltd. 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 / JP
	[2019/23]
Former [2013/35]	For all designated states Dainippon Sumitomo Pharma Co., Ltd. 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 / JP
Inventor(s)	01 / NAKAGAWA, Takashi c/o Dainippon Sumitomo Pharma Co. Ltd. 3-45 Kurakakiuchi 1-chome Ibaraki-shi Osaka 567-0878 / JP
	02 / KOSEKI, Norimasa c/o Dainippon Sumitomo Pharma Co. Ltd. 3-45 Kurakakiuchi 1-chome Ibaraki-shi Osaka 567-0878 / JP
	[2013/35]
Representative(s)	Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE
	[N/P]
Former [2013/35]	Vossius & Partner Siebertstrasse 4 81675 München / DE
Application number, filing date	11834492.8	18.10.2011
	WO2011JP74375
Priority number, date	US20100394069P	18.10.2010 Original published format: US 394069 P
	[2013/35]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012053654
	Date:	26.04.2012
	Language:	EN
	[2012/17]
	Type:	A1 Application with search report
	No.:	EP2629775
	Date:	28.08.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.04.2012 takes the place of the publication of the European patent application.
	[2013/35]
Search report(s)	International search report - published on:	JP	26.04.2012
	(Supplementary) European search report - dispatched on:	EP	09.05.2014
Classification	IPC:	A61K31/496, A61K9/10, A61K47/02, A61K47/26, C07D417/12	[2018/47]
	CPC:	C07D417/12 (EP,US); A61K31/496 (EP,KR,US); A61K47/02 (EP,US); A61K47/12 (KR); A61K47/16 (KR); A61K47/20 (KR); (+) A61K47/26 (EP,US); A61K47/34 (KR); A61K9/0019 (EP,US); A61K9/08 (KR); A61K9/10 (EP,US); A61P25/00 (EP); A61P25/18 (EP); A61P25/24 (EP) (-)
	Former IPC [2014/23]	A61K31/496, A61K9/10, A61K47/12, A61K47/16, A61K47/20, A61K47/34, C07D417/12
	Former IPC [2013/35]	A61K31/496, A61K9/08, A61K47/12, A61K47/16, A61K47/20, A61K47/34, C07D417/12
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/35]
Title	German:	INJIZIERBARE FORMULIERUNG MIT VERZÖGERTER FREISETZUNG	[2013/35]
	English:	SUSTAINED-RELEASE FORMULATION FOR INJECTION	[2013/35]
	French:	FORMULATION À LIBÉRATION PROLONGÉE POUR INJECTION	[2013/35]
Entry into regional phase	10.05.2013	National basic fee paid
	10.05.2013	Search fee paid
	10.05.2013	Designation fee(s) paid
	10.05.2013	Examination fee paid
Examination procedure	10.05.2013	Examination requested [2013/35]
	08.12.2014	Amendment by applicant (claims and/or description)
	18.03.2016	Despatch of a communication from the examining division (Time limit: M06)
	28.09.2016	Reply to a communication from the examining division
	06.03.2018	Despatch of a communication from the examining division (Time limit: M04)
	17.04.2018	Reply to a communication from the examining division
	14.12.2018	Communication of intention to grant the patent
	23.04.2019	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	29.05.2019	Communication of intention to grant the patent
	08.10.2019	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	30.01.2020	Communication of intention to grant the patent
	10.06.2020	Application deemed to be withdrawn, date of legal effect [2020/47]
	01.07.2020	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2020/47]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.03.2016
Fees paid	Renewal fee
	24.10.2013	Renewal fee patent year 03
	27.10.2014	Renewal fee patent year 04
	23.10.2015	Renewal fee patent year 05
	21.10.2016	Renewal fee patent year 06
	23.10.2017	Renewal fee patent year 07
	22.10.2018	Renewal fee patent year 08
	23.10.2019	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]EP1884242 (DAINIPPON SUMITOMO PHARMA CO [JP]) [A] 27 * page 16; table 22 *
		[XP] - "CRYSATLLINE FORM OF (3AR, 4S, 7R, 7AS)-2-[(1R, 2R)-2-[4-(1, 2-BENZISOTHIAZOL-3-YL)-PIPERAZIN-1-YLMETHYL]-CYCLOHEXYLMETHYL] HEXAHYDRO-4, 7- METHANO-2HISOINDOLE-1, 3- DIONE", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, (20110328), ISSN 1533-0001, XP013144503 [XP] 27,28 * the whole document *
	International search	[Y]JPH0517440 (SUMITOMO PHARMA);
		[Y]JP2005533093 (NOVARTIS AKTIENGESELLSCHAFT);
		[Y]WO2006134864 (DAINIPPON SUMITOMO PHARMA CO [JP], et al);
		[Y] - SADASUKE, OKANO. ET AL., KABUSHIKI KAISHA NANKOUDOU, (1987), pages 76 - 81, XP008170284
		[Y] - MASAYOSHI, HORIOKA., CHUUSHAZAI - SONO KISO TO CHOUZAI TO TEKIYOU -. KABUSHIKI KAISHA NANZANDOU, (1995), pages 23 - 5, XP008170282

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p